Applied Biotechnology Institute, Inc

Description

Applied Biotechnology Institute is dedicated to providing health and environmental benefits to society. ABI uses its proprietary animal-free system to produce recombinant proteins and develop sustainable solutions. We form partnerships with other companies for latter stages of product development, production and sales. To learn more about our unique platform, click here.

Prior to ABI, Dr. Howard founded ProdiGene, a biotechnology company focused on biopharmaceuticals and industrial products from plants. Before ProdiGene, Dr. Howard was director of Protein Products at Pioneer Hi-Bred International, Inc., where he initiated and developed a program to develop and produce recombinant protein products from plants. From 1987 to 1994, he was director of the Biotechnology Research Department at Pioneer which developed new traits and technology for a variety of crops.

John Howard has over 30 years' experience in directing biotechnology groups in research, regulatory, production, intellectual property, and business development for two Fortune 500 companies and two start-up companies. In addition to directing a number of technology innovations, he also directed the commercial introduction of the first plant biotechnology products for crop improvement and the first industrial and human health products produced from transgenic plants. He is an author on over 100 publications and patents in biotechnology. Dr.

Celine Hayden leads the vaccine program at ABI and brings over 15 years of experience in molecular and biochemical techniques. Since arriving at ABI, she has directed all aspects of research development, preclinical studies, regulatory compliance, and product development for oral vaccine candidates. Dr. Hayden has also been instrumental in developing bioscavenger and other pharmaceutical proteins using ABI’s plant expression platform.

Products & services

Similar companies nearby